{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:51:06Z","timestamp":1787028666617,"version":"build-2736575974"},"reference-count":104,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T00:00:00Z","timestamp":1766620800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiac amyloidosis is an underdiagnosed cause of heart failure characterized by extracellular deposition of misfolded proteins. Advances in non-invasive imaging, including echocardiography, cardiac magnetic resonance imaging (CMR), and radionuclide imaging, have significantly enhanced the diagnostic accuracy and monitoring of cardiac amyloidosis. This review explores the role of each modality, their individual strengths, and current consensus recommendations. Emphasis is placed on the integration of multimodal imaging to guide diagnosis, prognosis, and therapeutic decisions in both AL and ATTR amyloidosis.<\/jats:p>","DOI":"10.3390\/jcm15010163","type":"journal-article","created":{"date-parts":[[2025,12,25]],"date-time":"2025-12-25T23:52:27Z","timestamp":1766706747000},"page":"163","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Multimodality Imaging in Cardiac Amyloidosis"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4925-8347","authenticated-orcid":false,"given":"Mayuresh","family":"Chaudhari","sequence":"first","affiliation":[{"name":"UT Health Sciences Centre, Glen Biggs Institute, San Antonio, TX 78229, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahi Lakshmi","family":"Ashwath","sequence":"additional","affiliation":[{"name":"UHS\/UT Heart and Vascular Institute, San Antonio, TX 78229, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,12,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCULATIONAHA.111.078915","article-title":"Transthyretin (TTR) cardiac amyloidosis","volume":"126","author":"Ruberg","year":"2012","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.7861\/clinmedicine.18-2-s30","article-title":"Cardiac amyloidosis","volume":"18","author":"Hawkins","year":"2018","journal-title":"Clin. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Robles","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jchf.2013.11.004","article-title":"Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction","volume":"2","author":"Mohammed","year":"2014","journal-title":"JACC Heart Fail."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMra023144","article-title":"Molecular mechanisms of amyloidosis","volume":"349","author":"Merlini","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/heartjnl-2016-310704","article-title":"Light-chain cardiac amyloidosis: Strategies to promote early diagnosis and cardiac response","volume":"103","author":"Grogan","year":"2017","journal-title":"Heart"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/clc.23572","article-title":"Cardiac amyloidosis-A review of current literature for the practicing physician","volume":"44","author":"Ash","year":"2021","journal-title":"Clin. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1006\/jsbi.2000.4273","article-title":"Review: TTR amyloidosis\u2014Structural features leading to protein aggregation and their implications on therapeutic strategies","volume":"130","author":"Damas","year":"2000","journal-title":"J. Struct. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jacc.2016.06.053","article-title":"AL (Light-Chain) cardiac amyloidosis: A Review of Diagnosis and Therapy","volume":"68","author":"Falk","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e002310","DOI":"10.1136\/openhrt-2023-002310","article-title":"Prognosis of light chain amyloidosis: A multivariable analysis for survival prediction in patients with cardiac involvement proven by endomyocardial biopsy","volume":"10","author":"Aurich","year":"2023","journal-title":"Open Heart"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.recesp.2017.05.018","article-title":"Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope","volume":"70","year":"2017","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jcpt.12145","article-title":"Recent progress in the understanding and treatment of transthyretin amyloidosis","volume":"39","author":"Sekijima","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e003815","DOI":"10.1161\/CIRCHEARTFAILURE.116.003815","article-title":"Design and Rationale of the Phase 3 ATTR-ACT Clinical Trial (Tafamidis in Transthyretin Cardiomyopathy Clinical Trial)","volume":"10","author":"Maurer","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: An equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.lpm.2013.03.004","article-title":"Senile systemic amyloidosis: Definition, diagnosis, why thinking about?","volume":"42","author":"Damy","year":"2013","journal-title":"Presse Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin Amyloid Cardiomyopathy: JACC State-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ejheart.2007.01.012","article-title":"Non-invasive predictors of survival in cardiac amyloidosis","volume":"9","author":"Kristen","year":"2007","journal-title":"Eur. J. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1016\/j.jacc.2018.07.092","article-title":"Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release","volume":"72","author":"Sperry","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jacc.2016.03.596","article-title":"Genotype and Phenotype of Transthyretin Cardiac Amyloidosis: THAOS (Transthyretin Amyloid Outcome Survey)","volume":"68","author":"Maurer","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jacc.2003.08.043","article-title":"Noninvasive diagnosis of biopsy-proven cardiac amyloidosis","volume":"43","author":"Rahman","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.amjcard.2004.10.028","article-title":"Electrocardiographic findings in primary systemic amyloidosis and biopsy-proven cardiac involvement","volume":"95","author":"Murtagh","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/qjmed\/91.2.141","article-title":"The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement","volume":"91","author":"Dubrey","year":"1998","journal-title":"QJM"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1182\/blood-2004-01-0390","article-title":"Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/ajh.23141","article-title":"Best use of cardiac biomarkers in patients with AL amyloidosis and renal failure","volume":"87","author":"Palladini","year":"2012","journal-title":"Am. J. Hematol."},{"key":"ref_33","first-page":"45","article-title":"Primary systemic amyloidosis: Clinical and laboratory features in 474 cases","volume":"32","author":"Kyle","year":"1995","journal-title":"Semin. Hematol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/138161282104141204143657","article-title":"Contemporary treatment of amyloid heart disease","volume":"21","author":"Palecek","year":"2015","journal-title":"Curr. Pharm. Des."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e08","DOI":"10.15420\/cfr.2022.26","article-title":"Role of Imaging in Cardiomyopathies","volume":"9","author":"Castiglione","year":"2023","journal-title":"Card. Fail. Rev."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e005407","DOI":"10.1161\/CIRCHEARTFAILURE.118.005407","article-title":"Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States","volume":"12","author":"Gilstrap","year":"2019","journal-title":"Circ. Heart Fail."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/jamacardio.2021.3070","article-title":"Prevalence of Transthyretin Amyloid Cardiomyopathy in Heart Failure with Preserved Ejection Fraction","volume":"6","author":"AbouEzzeddine","year":"2021","journal-title":"JAMA Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM200004133421502","article-title":"Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy","volume":"342","author":"Felker","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"A31","DOI":"10.1016\/j.echo.2022.06.006","article-title":"Practical Points for Echocardiography in Cardiac Amyloidosis","volume":"35","author":"Cuddy","year":"2022","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1586\/erc.10.41","article-title":"Cardiac amyloidosis: An approach to diagnosis and management","volume":"8","author":"Halwani","year":"2010","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jcmg.2015.05.014","article-title":"Causes and Consequences of Longitudinal LV Dysfunction Assessed by 2D Strain Echocardiography in Cardiac Amyloidosis","volume":"9","author":"Ternacle","year":"2016","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.jacc.2007.08.028","article-title":"Evaluation and management of the cardiac amyloidosis","volume":"50","author":"Selvanayagam","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","first-page":"1128","article-title":"Left atrial structure and function in cardiac amyloidosis","volume":"18","author":"Nochioka","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10554-020-01948-9","article-title":"Left atrial strain imaging differentiates cardiac amyloidosis and hypertensive heart disease","volume":"37","author":"Rausch","year":"2021","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.recesp.2023.06.017","article-title":"Monitoring cardiac amyloidosis with multimodality imaging","volume":"77","author":"Starr","year":"2024","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e005588","DOI":"10.1161\/CIRCIMAGING.116.005588","article-title":"Echo Parameters for Differential Diagnosis in Cardiac Amyloidosis: A Head-to-Head Comparison of Deformation and Nondeformation Parameters","volume":"10","author":"Pagourelias","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/heartjnl-2015-308657","article-title":"Prognostic implication of relative regional strain ratio in cardiac amyloidosis","volume":"102","author":"Senapati","year":"2016","journal-title":"Heart"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"4139","DOI":"10.1002\/ehf2.15013","article-title":"Diagnostic and prognostic value of the left atrial myopathy evaluation in cardiac amyloidosis using echocardiography","volume":"11","author":"Ferkh","year":"2024","journal-title":"ESC Heart Fail."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/13506129.2018.1430027","article-title":"Reduced left atrial myocardial deformation irrespective of cavity size: A potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis","volume":"25","author":"Henein","year":"2018","journal-title":"Amyloid"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e034723","DOI":"10.1161\/JAHA.124.034723","article-title":"Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis","volume":"13","author":"Annabi","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcmg.2009.09.023","article-title":"Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis","volume":"3","author":"Syed","year":"2010","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1161\/01.CIR.0000152819.97857.9D","article-title":"Cardiovascular magnetic resonance in cardiac amyloidosis","volume":"111","author":"Maceira","year":"2005","journal-title":"Circulation"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Maggialetti, N., Torrente, A., Lorusso, G., Villanova, I., Ficco, M., Gravina, M., Ferrari, C., Giordano, L., Granata, V., and Rubini, D. (2024). Role of Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: A Narrative Review. J. Pers. Med., 14.","DOI":"10.3390\/jpm14040407"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/j.jcmg.2020.03.010","article-title":"Native, T1 Mapping, Extracellular Volume Mapping, and Late Gadolinium Enhancement in Cardiac Amyloidosis: A Meta-Analysis","volume":"13","author":"Pan","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/joim.12324","article-title":"Measurement of myocardial amyloid deposition in systemic amyloidosis: Insights from cardiovascular magnetic resonance imaging","volume":"277","author":"Barison","year":"2015","journal-title":"J. Intern. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jcmg.2012.11.013","article-title":"Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis","volume":"6","author":"Karamitsos","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jcmg.2013.08.015","article-title":"CMR-based differentiation of AL and ATTR cardiac amyloidosis","volume":"7","author":"Dungu","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12968-014-0069-x","article-title":"Reference values for healthy human myocardium using a T1 mapping methodology: Results from the International T1 Multicenter cardiovascular magnetic resonance study","volume":"16","author":"Dabir","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.amjcard.2008.09.105","article-title":"Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis","volume":"103","author":"Ruberg","year":"2009","journal-title":"Am. J. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jcmg.2013.09.019","article-title":"CMR imaging with rapid visual T1 assessment predicts mortality in patients suspected of cardiac amyloidosis","volume":"7","author":"White","year":"2014","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40119-021-00222-w","article-title":"Multidisciplinary Approaches for Transthyretin Amyloidosis","volume":"10","author":"Koike","year":"2021","journal-title":"Cardiol. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.111.089409","article-title":"Association between extracellular matrix expansion quantified by cardiovascular magnetic resonance and short-term mortality","volume":"126","author":"Wong","year":"2012","journal-title":"Circulation"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin Cardiac Amyloidosis","volume":"70","author":"Treibel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12968-017-0389-8","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI)","volume":"19","author":"Messroghli","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Patel","year":"2022","journal-title":"Eur. Heart J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e004770","DOI":"10.1161\/CIRCIMAGING.116.004770","article-title":"Serial Native T1 Mapping to Monitor Cardiac Response to Treatment in Light-Chain Amyloidosis","volume":"9","author":"Hur","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_68","first-page":"178","article-title":"Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management","volume":"32","author":"Hassan","year":"2005","journal-title":"Tex. Heart Inst. J."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CRD.0b013e3181bdba8f","article-title":"Cardiac amyloidosis: Approaches to diagnosis and management","volume":"18","author":"Desai","year":"2010","journal-title":"Cardiol. Rev."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"(99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"102019","DOI":"10.1016\/j.nuclcard.2024.102019","article-title":"Quantitative 99mTc-pyrophosphate myocardial uptake: Changes on transthyretin stabilization therapy","volume":"39","author":"Vijayakumar","year":"2024","journal-title":"J. Nucl. Cardiol."},{"key":"ref_73","first-page":"71","article-title":"A case of cardiac amyloidosis incidentally detected by bone scintigraphy","volume":"9","author":"Tanaka","year":"2021","journal-title":"Asia Ocean J. Nucl. Med. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/ehjci\/jew325","article-title":"Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jcmg.2011.03.016","article-title":"Role of (99m)Tc-DPD scintigraphy in diagnosis and prognosis of hereditary transthyretin-related cardiac amyloidosis","volume":"4","author":"Rapezzi","year":"2011","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_76","first-page":"2008","article-title":"Expansion of the National Amyloidosis Centre staging system to detect early mortality in transthyretin cardiac amyloidosis","volume":"26","author":"Nitsche","year":"2024","journal-title":"Eur. J. Heart Fail."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1007\/s00259-014-2787-6","article-title":"Imaging cardiac amyloidosis: A pilot study using 18F-florbetapir positron emission tomography","volume":"41","author":"Dorbala","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jcmg.2014.09.018","article-title":"11C-Pittsburgh B PET imaging in cardiac amyloidosis","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2025.06.009","article-title":"Regression of Myocardial Bone-Avid Tracer Uptake After ATTR-CM Disease-Modifying Therapy: Is This a New Post-Treatment Phenotype?","volume":"18","author":"Dorbala","year":"2025","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/CIR.0000000000000792","article-title":"Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association","volume":"142","author":"Kittleson","year":"2020","journal-title":"Circulation"},{"key":"ref_81","first-page":"e000030","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis: Part 2 of 2-Diagnostic Criteria and Appropriate Utilization","volume":"14","author":"Dorbala","year":"2021","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000508022","article-title":"Confirming the Diagnosis of Amyloidosis","volume":"143","author":"Wisniowski","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","article-title":"Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis","volume":"23","author":"DeLuca","year":"2016","journal-title":"J. Nucl. Cardiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1002\/jcu.23271","article-title":"Multimodality imaging in cardiac amyloidosis: State-of-the-art review","volume":"50","author":"Rosa","year":"2022","journal-title":"J. Clin. Ultrasound"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/ehjci\/jead107","article-title":"Relative apical sparing in cardiac amyloidosis is not always explained by an amyloid gradient","volume":"24","author":"Sinigiani","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s12350-015-0176-6","article-title":"(99m)Tc-HMDP scintigraphy rectifies wrong diagnosis of AL amyloidosis","volume":"22","author":"Galat","year":"2015","journal-title":"J. Nucl. Cardiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/wjnm.WJNM_25_20","article-title":"Potential diagnostic pitfalls of bone scintigraphy in transthyretin-related amyloidosis","volume":"19","author":"Meristoudis","year":"2020","journal-title":"World J. Nucl. Med."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.acvd.2013.06.051","article-title":"Cardiac amyloidosis: Updates in diagnosis and management","volume":"106","author":"Mohty","year":"2013","journal-title":"Arch. Cardiovasc. Dis."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMra2304088","article-title":"Systemic Light Chain Amyloidosis","volume":"390","author":"Sanchorawala","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_90","first-page":"2000","article-title":"Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens","volume":"113","author":"Vrana","year":"2009","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.jcmg.2023.07.007","article-title":"Cardiac Amyloid Quantification Using 124I-Evuzamitide (124I-P5+14) Versus 18F-Florbetapir: A Pilot PET\/CT Study","volume":"16","author":"Clerc","year":"2023","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref_92","unstructured":"(2024). Publication of Studies Evaluating 124I-Evuzamitide for PET\/CT Detection of Cardiac Amyloidosis, Attralus Press Release."},{"key":"ref_93","first-page":"Epub ahead of print","article-title":"A tale of two tracers\u2014Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05)","volume":"102451","author":"Martin","year":"2025","journal-title":"J. Nucl. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jcmg.2025.01.018","article-title":"Early Detection of Transthyretin Cardiac Amyloidosis Using 124I-Evuzamitide Positron Emission Tomography\/Computed Tomography","volume":"18","author":"Smiley","year":"2025","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.jacc.2022.01.036","article-title":"Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review","volume":"79","author":"Rapezzi","year":"2022","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tcm.2019.12.003","article-title":"Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction","volume":"31","author":"Griffin","year":"2021","journal-title":"Trends Cardiovasc. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/ehjci\/jeaa063","article-title":"Multimodality imaging in cardiac amyloidosis: A primer for cardiologists","volume":"21","author":"Jurcut","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial Edema and Prognosis in Amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1001\/jama.2024.0442","article-title":"Cardiac Amyloidosis Due to Transthyretin Protein: A Review","volume":"331","author":"Ruberg","year":"2024","journal-title":"JAMA"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1001\/jamacardio.2023.2010","article-title":"Tracking Treatment Response in Cardiac Light-Chain Amyloidosis With Native T1 Mapping","volume":"8","author":"Ioannou","year":"2023","journal-title":"JAMA Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2967\/jnmt.123.265415","article-title":"Cardiac Amyloidosis Imaging, Part 1: Amyloidosis Etiology and Image Acquisition","volume":"51","author":"Farrell","year":"2023","journal-title":"J. Nucl. Med. Technol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s12350-019-01740-w","article-title":"Diagnosing cardiac amyloidosis: A wealth of new possibilities with nuclear cardiac imaging","volume":"28","year":"2021","journal-title":"J. Nucl. Cardiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1148\/rg.2020200068","article-title":"Radionuclide Imaging of Cardiac Amyloidosis and Sarcoidosis: Roles and Characteristics of Various Tracers","volume":"40","author":"Hotta","year":"2020","journal-title":"Radiographics"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jcmg.2025.04.007","article-title":"Primary Left Atrial Cardiopathy in Transthyretin Amyloidosis Cardiomyopathy by Multimodality Imaging: Implications for Thrombotic Events","volume":"18","author":"Ozbay","year":"2025","journal-title":"JACC Cardiovasc. Imaging"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/163\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:08:45Z","timestamp":1766707725000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/1\/163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,25]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["jcm15010163"],"URL":"https:\/\/doi.org\/10.3390\/jcm15010163","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,25]]}}}